| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.03 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.092 | 0.03 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.03 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |